What happens when there’s not enough parathyroid hormone (PTH), or when there’s too much? How is the skeletal system impacted? These were questions international expert Professor John Bilezikian, a Silberberg Professor of Medicine and Pharmacology at the College of Physicians and Surgeons, Columbia University, discussed during a recent talk at Amgen One’ Bone Academy conference ...
Parathyroid hormone, one molecule, three diseases
29 Apr 2019
Sponsored by Amgen Australia Pty Ltd